The following table presents the fair values of the Company's derivative financial instruments included in the Consolidated Balance Sheets as of April 30, 2026, January 31, 2026 and April 30, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
Balance
Sheet
Location |
|
April 30,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
April 30,
2025
Fair
Value |
|
|
Balance
Sheet
Location |
|
April 30,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
April 30,
2025
Fair
Value |
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Contracts |
|
Other Current
Assets |
|
$ |
21 |
|
|
$ |
— |
|
|
$ |
— |
|
|
Accrued
Liabilities |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,263 |
|
Total Derivative Instruments |
|
|
|
$ |
21 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
Balance
Sheet
Location |
|
April 30,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
April 30,
2025
Fair
Value |
|
|
Balance
Sheet
Location |
|
April 30,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
April 30,
2025
Fair
Value |
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Contracts |
|
Other Current
Assets |
|
$ |
44 |
|
|
$ |
484 |
|
|
$ |
1,255 |
|
|
Accrued
Liabilities |
|
$ |
103 |
|
|
$ |
10 |
|
|
$ |
— |
|
Total Derivative Instruments |
|
|
|
$ |
44 |
|
|
$ |
484 |
|
|
$ |
1,255 |
|
|
|
|
$ |
103 |
|
|
$ |
10 |
|
|
$ |
— |
|
|